Department of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
Histopathology. 2020 Jun;76(7):1005-1012. doi: 10.1111/his.14103. Epub 2020 May 15.
Biliary intraductal tubular neoplasms that are non-mucinous and negative for mucin 5AC (MUC5AC) are called intraductal tubulopapillary neoplasms (ITPNs). Intraductal tubular neoplasms with mucinous cytoplasm and MUC5AC positivity also occur and their nature remains unclear, although some pathologists may classify these as 'intraductal papillary neoplasms of the bile duct (IPNBs) of gastric type'. This study aimed to elucidate genetic features of biliary intraductal tubular neoplasms.
Six resected cases of biliary intraductal neoplasm with >70% tubular configuration were characterised by clinicopathological examination and whole exome sequencing, and the findings obtained were compared between MUC5AC-negative (n = 2) and -positive cases (n = 4). The intraductal tumours consisted of the pancreatobiliary-type epithelium with high-grade dysplasia arranged in back-to-back tubules. Both of the two MUC5AC-negative cases were non-invasive neoplasms and developed in the liver, whereas all MUC5AC-positive cases had invasive carcinoma and were present in the intrahepatic (n = 2), perihilar (n = 1) and distal bile ducts (n = 1). In an exome-sequencing study, MUC5AC-negative cases harboured mutations in CTNNB1, SF3B1, BAP1 and BRCA1 (one case each). KRAS mutations were observed in three of four MUC5AC-positive cases (75%) but none of the MUC5AC-negative neoplasms. Compared to published data, known driver genes of other intraductal neoplasms of the pancreatobiliary system (e.g. APC, CTNNB1, STK11, GNAS and PIK3CA) were wild-type in all but one MUC5AC-negative case with CTNNB1 mutation. Chromatin modifiers (ARID1A, BAP1 and KMT2C) were also altered in MUC5AC-positive cases, similar to usual cholangiocarcinomas.
This exome-sequencing study suggested that MUC5AC-negative biliary ITPNs are genetically distinct from pancreatic ITPNs and IPNBs. They may also biologically differ from MUC5AC-positive tubular neoplasms despite morphological resemblance.
非黏液性且不表达黏蛋白 5AC(MUC5AC)的胆道管状内肿瘤称为管状内乳头状肿瘤(ITPNs)。也存在黏液性细胞质和 MUC5AC 阳性的管状内肿瘤,但其性质尚不清楚,尽管一些病理学家可能将这些肿瘤归类为“胃型胆管内乳头状肿瘤(IPNBs)”。本研究旨在阐明胆道管状内肿瘤的遗传特征。
对 6 例管状结构>70%的胆道内肿瘤进行了临床病理检查和全外显子组测序,并对 MUC5AC 阴性(n=2)和阳性病例(n=4)的发现进行了比较。管状内肿瘤由高级别异型增生的胰胆管型上皮组成,呈背靠背管状排列。MUC5AC 阴性的 2 例均为非浸润性肿瘤,发生在肝脏,而 MUC5AC 阳性的 4 例均为浸润性癌,发生在肝内(n=2)、肝门部(n=1)和远端胆管(n=1)。在一项外显子组测序研究中,MUC5AC 阴性病例分别携带 CTNNB1、SF3B1、BAP1 和 BRCA1 的突变(各 1 例)。KRAS 突变在 4 例 MUC5AC 阳性病例中的 3 例(75%)中观察到,但在所有 MUC5AC 阴性肿瘤中均未观察到。与已发表的数据相比,其他胰胆管系统内肿瘤(如 APC、CTNNB1、STK11、GNAS 和 PIK3CA)的已知驱动基因在除携带 CTNNB1 突变的 1 例 MUC5AC 阴性病例外均为野生型。染色质修饰因子(ARID1A、BAP1 和 KMT2C)在 MUC5AC 阳性病例中也发生了改变,与普通胆管癌相似。
这项外显子组测序研究表明,MUC5AC 阴性的胆道 ITPN 在遗传上与胰腺 ITPN 和 IPNB 不同。尽管形态上相似,但它们可能在生物学上也与 MUC5AC 阳性的管状肿瘤不同。